학술논문

Pharmacokinetic and clinical monitoring through posologic changes in adalimumab intensification regimen from 40 mg every week to 80 mg every other week
Document Type
Article
Source
In: Revista Espanola de Enfermedades Digestivas. (Revista Espanola de Enfermedades Digestivas, 2022, 114(12):708-712)
Subject
Language
English
ISSN
11300108